NASDAQ:ADRO
Delisted
Aduro Biotech Stock News
$14.60
+0 (+0%)
At Close: May 27, 2022
29 Stocks Moving In Thursday's After-Hours Session
10:23pm, Thursday, 06'th Feb 2020
Gainers
2U (NASDAQ: TWOU) shares are trading higher after the company reported better-than-expected Q4 sales results.
Pinterest (NASDAQ: PINS) shares are trading higher after the...
Aduro Biotech, Inc. (ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL)
BDX, GLOP among premarket losers
02:27pm, Thursday, 06'th Feb 2020
Tonix Pharmaceuticals Holding (NASDAQ:TNXP) -58% on failed Tonmya study.ReWalk Robotics (NASDAQ:RWLK) -40% on pricing $7M public offering.Funko (NASDAQ:FNKO) -39% on preliminary Q4 results.GasLog
AMZN, NAV among premarket gainers
02:20pm, Friday, 31'st Jan 2020
Navistar International (NYSE:NAV) +55% with Volkswagen finally making move for acquisition.NanoViricides (NYSEMKT:NNVC) +42% after confirming work on coronavirus treatment.Lianluo Smart (NASDAQ:LL
East Bay cancer drug developer, jilted by Novartis, to cut 51 jobs
11:03pm, Friday, 10'th Jan 2020
Aduro Biotech Inc. will cut nearly 60% of its workforce and close its European office a month after Swiss partner Novartis AG stepped away from a four-year cancer drug collaboration. The Berkeley com
Biotechs punch up talking points leading into big Union Square conference
11:00pm, Friday, 10'th Jan 2020
Tenaya Therapeutics — named after a peak and lake at Yosemite National Park — is led by CEO Faraz Ali (right) and includes investments from Dave Goeddel's The Column Group.
Morgan Stanley sees 15% upside in McKesson in premarket analyst action
12:32pm, Friday, 10'th Jan 2020
Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Neutral rating and $27 (6% upside) price target at Bank of America.Aurinia Pharmaceuticals (AUP CN) initiated with Buy rating and C$35.26 (32% upside
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ultragenyx Pharmaceutical (RARE
Aduro Biotech Announces Corporate Restructuring
09:15pm, Thursday, 09'th Jan 2020
Aduro Biotech, Inc. (ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the immune system cGAS-STING and APRIL pathways for the treatment of cancer, autoimmune